Medtronic InFuse PMA Approval Sets Up CMS “New Technology” Add-On
This article was originally published in The Gray Sheet
Executive Summary
FDA's July 2 approval of Medtronic Sofamor Danek's InFuse bone graft/LT-Cage lumbar tapered fusion system arrives in time for the device to qualify for a Medicare "new technology" add-on payment
You may also be interested in...
Medtronic’s Restore, W.L. Gore’s Tag Receive New Tech Add-On Payment
Medtronic's argument that the Restore rechargeable implantable neurostimulator represents a substantial clinical improvement over existing devices convinced CMS to award the device new technology add-on payment for fiscal year 2007
Medtronic’s Restore, W.L. Gore’s Tag Receive New Tech Add-On Payment
Medtronic's argument that the Restore rechargeable implantable neurostimulator represents a substantial clinical improvement over existing devices convinced CMS to award the device new technology add-on payment for fiscal year 2007
Medtronic “Grooves Its Swing” With Widened InFuse Use, Cervical Disc Prep
FDA likely will require Medtronic Sofamor Danek to perform PMA clinical trials of multilevel fusion indications for its Bryan and Prestige artificial cervical discs, the company says